|
|
||||||||





*
Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia;
Flinders Medical Center, Bedford Park, South Australia, Australia;
Oklahoma Medical Research Foundation, University of Oklahoma, and U.S. Department of Veterans Affairs, Oklahoma City, OK 73104
We investigated the consequences of altering the form and valence of defined autodeterminants on the initiation and spreading of experimentally induced La/Ro autoimmunity. Anti-La and Ro (SS-A) Ab responses were monitored following immunization of healthy mice with defined immunodominant and subdominant T cell determinants of the La (SS-B) autoantigen synthesized as either monomeric or multiple antigenic (MAP) peptides. Abs to mouse La (mLa) developed faster and were of higher titer in mice immunized with the subdominant mLa2544 MAP compared with mice immunized with the 2544 monomer. Rapid intermolecular spreading of the autoimmune response to 60-kDa Ro was observed in AKR/J mice immunized with mLa2544 MAP, but not in mice immunized repeatedly with monomeric peptide. A/J mice immunized and boosted with the known tolerogenic mLa287301 determinant delivered as monomeric peptide failed to develop Abs to either intact mLa or mLa287301 peptide. However, immunization with the multivalent mLa287301 peptide led to the rapid production of high titer mLa autoantibodies associated with a proliferative T cell response to the mLa287301 peptide. The data suggested that the enhanced immunogenicity of MAPs was not due to augmented Ag presentation or T cell stimulation. However, MAP-, but not monomer peptide-, containing immune complexes were potent substrates for Ab-dependent fixation of complement. These results demonstrate that the form of Ag responsible for inducing autoimmunity can profoundly influence the nature and magnitude of the immune response. Thus, molecular mimicry of tolerogenic and nontolerogenic self determinants might trigger autoimmunity under conditions of altered valence.
This article has been cited by other articles:
![]() |
M. L. Nguyen, S. Terzyan, J. D. Ballard, J. A. James, and A. D. Farris The Major Neutralizing Antibody Responses to Recombinant Anthrax Lethal and Edema Factors Are Directed to Non-Cross-Reactive Epitopes Infect. Immun., November 1, 2009; 77(11): 4714 - 4723. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Nguyen, S. R. Crowe, S. Kurella, S. Teryzan, B. Cao, J. D. Ballard, J. A. James, and A. D. Farris Sequential B-Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal Toxin-Neutralizing Antibodies Infect. Immun., January 1, 2009; 77(1): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Scofield, S. Asfa, D. Obeso, R. Jonsson, and B. T. Kurien Immunization with Short Peptides from the 60-kDa Ro Antigen Recapitulates the Serological and Pathological Findings as well as the Salivary Gland Dysfunction of Sjogren's Syndrome J. Immunol., December 15, 2005; 175(12): 8409 - 8414. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cavacini, M. Duval, J. P. Eder, and M. R. Posner Evidence of Determinant Spreading in the Antibody Responses to Prostate Cell Surface Antigens in Patients Immunized with Prostate-specific Antigen Clin. Cancer Res., February 1, 2002; 8(2): 368 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khalil, K. Inaba, R. Steinman, J. Ravetch, and B. Diamond T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus J. Immunol., February 1, 2001; 166(3): 1667 - 1674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |